As flibanserin, the drug touted as the “female Viagra” struggles to get approved by the FDA, NOW wonders if sexism is at play.
“It looks to me like there are more hurdles being put in front of this drug than there have been on drugs addressing male dysfunction,” Terry O’Neill, NOW President, said.
There are currently 24 male desire, arousal or orgasm dysfunction medications on the market. There are zero available to women.